DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 12 · Volume 54 · December 2016 DOI: 10.1055/s-006-33008

Deutsche Arbeitsgemeinschaft zum Studium der Leber
33. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber
Essen, 20.–21.01.2017

Kongresspräsident: Prof. Dr. Guido Gerken

A2.1
Zenouzi, R; Yamamura, J; Keller, S; Sebode, M; Weiler-Normann, C; Lohse, AW; Schramm, C: Interpretation of follow-up 3D-MRCP/MRI in patients with primary sclerosing cholangitis
A2.2
Hamesch, K; Voß, J; Bretag, T; Spivak, I; Wetzel, M; Siegmund, B; Reichert, M; Lammert, F; Mandorfer, M; Trauner, M; Trautwein, C; Strnad, P: Multizentrische Studie zur Leberbeteiligung beim Alpha1-Antitrypsin-Mangel
A2.4
Janik, MK; Krawczyk, M; Kruk, B; Kostrzewa, K; Raszeja-Wyszomirska, J; Lammert, F; Milkiewicz, P: Shear wave elastography of the liver and spleen in patients with autoimmune hepatitis and its variants – A single centre study
A2.5
Jüngst, C; Stadlbauer-Köllner, V; Reichert, M; Weber, SN; Ofner-Ziegenfuß, L; Voigtländer, T; Spindelböck, W; Fickert, P; Kirchner, G; Lammert, F; Lankisch, TO; Krawczyk, M: NOD2 genetic variants confer risk for secondary sclerosing cholangitis in critically ill patients
A2.6
Bedreli, S; Rashidi, J; Willuweit, K; Piras-Straub, K; Khairzada, K; Gerken, G; Paul, A; Herzer, K: 3 Jahre Real-Life Essener Erfahrungen einer Everolimus-basierten Immunsuppression nach Lebertransplantation
A2.7
Bedreli, S; Sowa, JP; Katsounas, A; Blomeyer, S; Malek, S; Gerken, G; Saner, FH; Canbay, A: Evaluation eines Faktor XIII-Mangels mittels Rotationsthrombelastometrie (ROTEM®) bei Leberzirrhosepatienten mit Blutungsneigung
A2.8
Willuweit, K; Brandenburg, M; Sydor, S; Aßmuth, S; Wegehaupt, A; Kinner, S; Kahraman, A; Gerken, G; Canbay, A; Bechmann, LP: A non-invasive comparison between NASH and Crohn's disease
A2.9
Al-Herwi, EA; Stengel, S; Mai, M; Köse, N; Stallmach, A; Bruns, T: A TLR9 promoter polymorphism modulates the monocytic immune responses in decompensated cirrhosis
A2.11
Shahba, HH; Elbahrawy, AM; Helal, AE; Alashker, AM; Abdallah, AM; Hemeda, MH; Abd El-Moaty, ZH; Salah, AM; Abdel-Monem, SAA; Abdel-Hafeez, HA: Albumin creatinine ratio predicts medical intensive care unit outcome of patients with hepatic encephalopathy
A2.13
Mueller, S; Peccerella, T; Glassen, K; Flechtenmacher, C; Straub, B; Stickel, F; Bruckner, T; Bartsch, H; Seitz, HK: Carcinogenic Etheno DNA-Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P-450 and Fibrosis
A2.14
Nguyen-Tat, M; Austgen, T; Sivanathan, V; Sollinger, D; Rey, JW; Wörns, MA; Galle, PR; Marquardt, JU: Cell death biomarkers are associated with outcome in hepatorenal cirrhotic patients
A2.15
A2.16
Schwinge, D; Haxthausen, F von; Quaas, A; Carambia, A; Otto, B; Höh, B; Huber, S; Steffens, N; Günther, N; Lohse, AW; Herkel, J; Schramm, C: Dysfunction of hepatic regulatory T cells in experimental sclerosing cholangitis is associated with IL-12 signaling
A2.17
Kunzmann, LK; Schoknecht, T; Stein, S; Ehlken, H; Hartl, J; Pannicke, N; Peiseler, M; Sebode, M; Weiler-Normann, C; Zenouzi, R; Lohse, AW; Herkel, J; Schwinge, D; Schramm, C: Increased in vivo and in vitro TH17 differentiation in patients with Primary Sclerosing Cholangitis
A2.18
Gebauer, E; Ploch, PS; Sivanathan, V; Rahman, F; Wörns, MA; Galle, PR; Nguyen-Tat, M; Marquardt, JU: Elastografie bei akutem Leberversagen: eine prospektive Studie
A2.19
Büchter, M; Saner, FH; Katsounas, A; Penndorf, V; Gerken, G; Canbay, A; Dechêne, A: ERCP in critically ill patients unit is a safe procedure and does not increase mortality
A2.20
Reiners, D; Peiseler, M; Zenouzi, R; Sebode, M; Jung, F; Hartl, J; Ehlken, H; Huebener, S; Groth, S; Denzer, U; Schachschal, G; Rösch, T; Weiler-Normann, C; Lohse, AW; Schramm, C: ERCP in patients with PSC and cirrhosis is not associated with an increased rate of complications
A2.21
Niemietz, CJ; Sauer, V; Chandhok, G; Fleischhauer, L; Guttmann, S; Reinartz Groba, S; Zibert, A; Schmidt, HHJ: Evaluation of TTR toxicity in supernatants of FAP-derived hepatocyte-like cells
A2.22
A2.24
Itzel, T; Maass, T; Evert, M; Spang, R; Teufel, A: HCC prognostic signatures are not unique
A2.27
Yuan, X; Gu, W; Wandrer, F; Dewidar, B; Munker, S; Haehnel, B; Liebe, R; Ebert, MPA; Xia, Q; Bantel, H; Dooley, S; Li, H; Weng, HL: Lack of Polarity in liver progenitor cell-derived hepatocytes determines poor clinical outcome of acute-on-chronic liver failure
A2.30
Kneiseler, G; Bechmann, L; Dechêne, A; Baba, H; Gerken, G; Canbay, A: Postmortal diagnosis of hemophagocytic lymphohistiocytosis in a patient with liver failure of unknown etiology
A2.31
Kälsch, J; Keskin, H; Schütte, A; Baars, T; Baba, HA; Bechmann, LP; Sowa, JP; Canbay, A: Ultrasound diagnosis of hepatic steatosis represents increased metabolic risk
A2.33
Haderer, M; Kunst, C; Aschenbrenner, E; Pollinger, K; Middendorf, J; Schlosser, S; Müller-Schilling, M: Regulation of p53 – a possible bacterial defense mechanism leading to epithelial barrier destabilization in spontaneous bacterial peritonitis?
A2.37
Deterding, K; Spinner, CD; Schott, E; Welzel, TM; Gerken, G; Klinker, H; Spengler, U; Wiegand, J; Schulze zur Wiesch, J; Pathil, A; Cornberg, M; Umgelter, A; Zöllner, C; Zeuzem, S; Papkalla, A; Weber, K; Hardtke, S; der Leyen, H von; Koch, A; Witzendorff, D von; Manns, MP; Wedemeyer, H: Six weeks of Sofosbuvir/Ledipasvir treatment of acute hepatitis C Virus genotype 1 monoinfection: Final results of the German HepNet Acute HCV IV Study
A2.39
Lange, S; Glaser, N; Schultheiß, M; Thimme, R; Bettinger, D: The ALBI score: a new tool for decision making after TACE
A2.40
Bovensiepen, CS; Schakat, M; Sebode, M; Lohse, AW; Schramm, C; Herkel, J; Weiler-Normann, C: The Involvement of Tumor Necrosis Factor α in Autoimmune Hepatitis